Office of New Drugs Reorg Is Bigger Than Expected: US FDA Adds 11 Review Divisions

Executive Summary Long-planned OND 'modernization' to better match workflow, allow more time with stakeholders includes proposed restructuring that would boost number of offices overseeing review operations (adding four for a total of nine) and drug review divisions (adding 11 for a total of 30). Register for our free email digests:

Executive Summary

Long-planned OND 'modernization' to better match workflow, allow more time with stakeholders includes proposed restructuring that would boost number of offices overseeing review operations (adding four for a total of nine) and drug review divisions (adding 11 for a total of 30).

Register for our free email digests:

FDA entrance sign 2016
Source: pink.pharmaintelligence.informa.com